{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:35:26Z","timestamp":1761708926484},"reference-count":35,"publisher":"Elsevier BV","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.vaccine.2013.05.108","type":"journal-article","created":{"date-parts":[[2013,11,11]],"date-time":"2013-11-11T10:47:15Z","timestamp":1384166835000},"page":"I32-I41","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"S8","title":["Burden of Human Papillomavirus Infection and Related Diseases in Israel"],"prefix":"10.1016","volume":"31","author":[{"given":"Oren","family":"Shavit","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Roura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Micha","family":"Barchana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mireia","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob","family":"Bornstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2013.05.108_bib0005","series-title":"Population, by Population Group. Monthly Bulletin of Statistics (Israel Central Bureau of Statistics)","year":"2012"},{"key":"10.1016\/j.vaccine.2013.05.108_bib0010","series-title":"Latest Population Statistics for Israel. Jewish Virtual Library","year":"2013"},{"key":"10.1016\/j.vaccine.2013.05.108_bib0015","series-title":"GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 10 [Internet]","author":"Ferlay","year":"2010"},{"key":"10.1016\/j.vaccine.2013.05.108_bib0020","first-page":"120","article-title":"The low incidence of cervical cancer in Jewish women: has the puzzle finally been solved?","volume":"5","author":"Menczer","year":"2003","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.vaccine.2013.05.108_bib0025","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1056\/NEJMoa011688","article-title":"International Agency for Research on Cancer Multicenter Cervical Study Group Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners","volume":"346","author":"Castellsagu\u00e9","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2013.05.108_bib0030","first-page":"700","article-title":"Cervical neoplasia in Israeli Jewish women: characteristics in a low risk population","volume":"13","author":"Menczer","year":"2011","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.vaccine.2013.05.108_bib0190","doi-asserted-by":"crossref","first-page":"I42","DOI":"10.1016\/j.vaccine.2012.06.099","article-title":"Cervical cancer screening, human papillo-mavirus vaccination practices and current infrastructure in Israel","volume":"31S","author":"Schejter","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.05.108_bib0180","unstructured":"National Cancer Registry, Israel Ministry of Health. Israel National Health Insurance Law 1994. Available at: http:\/\/www.health.gov.il\/English\/MinistryUnits\/HealthDivision\/Icdc\/Icrc\/Pages\/default.aspx [last accessed January 2013]."},{"key":"10.1016\/j.vaccine.2013.05.108_bib0185","unstructured":"Israel Central Bureau of Statistics. Statistical abstract of Israel 2011. Available at: http:\/\/www1.cbs.gov.il\/ts\/databank\/search_databank_e.html?input_databank?input_databank=death [last accessed January 2013]."},{"key":"10.1016\/j.vaccine.2013.05.108_bib0050","volume":"vol. IX","author":"Curado","year":"2007"},{"issue":"2","key":"10.1016\/j.vaccine.2013.05.108_bib0055","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2165\/11594780-000000000-00000","article-title":"Evaluating the epidemiology and morbidity burden associated with human papillomavirus in Israel: accounting for CIN1 and genital warts in addition to CIN2\/3 and cervical cancer","volume":"10","author":"Shavit","year":"2012","journal-title":"Appl Health Econ Health Policy"},{"issue":"7","key":"10.1016\/j.vaccine.2013.05.108_bib0060","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.puhe.2012.04.005","article-title":"Uptake of Pap smears among women in a large Israeli HMO between 2006 and 2008","volume":"126","author":"Raz","year":"2012","journal-title":"Public Health"},{"key":"10.1016\/j.vaccine.2013.05.108_bib0065","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1158\/1055-9965.EPI-12-1173","article-title":"Sociodemographic inequalities in sexual activity and cervical cancer screening: implications for the success of human papillomavirus vaccination","volume":"22","author":"Drolet","year":"2013","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"6","key":"10.1016\/j.vaccine.2013.05.108_bib0070","doi-asserted-by":"crossref","first-page":"e394","DOI":"10.1016\/j.canep.2012.08.009","article-title":"Cervical cancer screening in Middle Eastern and Asian migrants to Australia: a record linkage study","volume":"36","author":"Aminisani","year":"2012","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.vaccine.2013.05.108_bib0075","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1159\/000162228","article-title":"A comparison of some epidemiological aspects of cervical and endometrial carcinoma","volume":"35","author":"Modan","year":"1970","journal-title":"Pathol Microbiol (Basel)"},{"key":"10.1016\/j.vaccine.2013.05.108_bib0080","first-page":"536","article-title":"Clinicoepidemiologic study of uterine cancer. Comparative aspects of the endometrial and cervical sites","volume":"50","author":"Sharon","year":"1977","journal-title":"Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.vaccine.2013.05.108_bib0085","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1002\/1097-0142(197806)41:6<2464::AID-CNCR2820410655>3.0.CO;2-D","article-title":"Adenocarcinoma of uterine cervix in Jewish women \u2013 distinct epidemiological entity","volume":"41","author":"Menczer","year":"1978","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.vaccine.2013.05.108_bib0090","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1111\/IGC.0b013e3181a84035","article-title":"Incidence rates of cervical carcinoma among first- and second-generation women of North African origin in Israel","volume":"19","author":"Menczer","year":"2009","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"10.1016\/j.vaccine.2013.05.108_bib0095","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1080\/00016340902730391","article-title":"Incidence trends of cervical adenocarcinoma in Israeli Jewish women: a population-based study","volume":"88","author":"Menczer","year":"2009","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"3","key":"10.1016\/j.vaccine.2013.05.108_bib0100","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/0090-8258(90)90245-G","article-title":"A cohort analysis of cervical cancer in Israeli Jewish women","volume":"39","author":"Heering","year":"1990","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.vaccine.2013.05.108_bib0105","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00404-010-1399-z","article-title":"A population based study of selected demographic characteristics of Israeli Jewish women with cervical squamous cell carcinoma","volume":"283","author":"Menczer","year":"2011","journal-title":"Arch Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2013.05.108_bib0110","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1046\/j.1525-1438.2002.01124.x","article-title":"Codon 72 polymorphism of p53 in Israeli Jewish cervical cancer and healthy women","volume":"12","author":"Arbel-Alon","year":"2002","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.vaccine.2013.05.108_bib0115","series-title":"Finnish Cancer Registry, Institute for Statistical and Epidemiological Cancer Research","year":"2011"},{"key":"10.1016\/j.vaccine.2013.05.108_bib0120","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s00404-002-0371-y","article-title":"Premalignant lesions of the uterine cervix in a large cohort of Israeli Jewish women","volume":"269","author":"Sadan","year":"2004","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.vaccine.2013.05.108_bib0125","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/LGT.0b013e3181652de2","article-title":"Risk factor proportions in Israeli patients with cervical intraepithelial neoplasia 3 and invasive squamous cell carcinoma","volume":"12","author":"Menczer","year":"2008","journal-title":"J Low Genit Tract Dis"},{"key":"10.1016\/j.vaccine.2013.05.108_bib0130","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1128\/JCM.02483-07","article-title":"Pilot study of prevalence of high-risk human papillomavirus genotypes in Israeli Jewish women referred for colposcopic examination","volume":"46","author":"Grisaru","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2013.05.108_bib0135","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1600-0528.2009.00493.x","article-title":"Trends of oral and pharyngeal cancer in Israel, by gender, age, ethnic group, and country of origin: 1970\u20132006","volume":"37","author":"Zini","year":"2009","journal-title":"Community Dent Oral Epidemiol"},{"key":"10.1016\/j.vaccine.2013.05.108_bib0140","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1600-0714.2009.00845.x","article-title":"Oral cancer over four decades: epidemiology, trends, histology, and survival by anatomical sites","volume":"39","author":"Zini","year":"2010","journal-title":"J Oral Pathol Med"},{"issue":"1","key":"10.1016\/j.vaccine.2013.05.108_bib0145","first-page":"30","article-title":"The presence of HPV 16, 18 and p53 immunohistochemical staining in tumor tissue of Israeli Jewish women with cervical and vulvar neoplasia","volume":"21","author":"Menczer","year":"2000","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1016\/j.vaccine.2013.05.108_bib0150","first-page":"837","article-title":"Human papillomavirus types in women with cervical cancer in Haifa district","volume":"150","author":"Siegler","year":"2011","journal-title":"Harefuah"},{"key":"10.1016\/j.vaccine.2013.05.108_bib0155","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study","volume":"11","author":"de Sanjos\u00e9","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.vaccine.2013.05.108_bib0160","first-page":"34","article-title":"The prevalence of human papillomavirus and cervical cytology abnormalities in women infected with human immunodeficiency virus in southern Israel","volume":"13","author":"Leibenson","year":"2011","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.vaccine.2013.05.108_bib0165","first-page":"349","article-title":"Prevalence of human papillomavirus infection and HPV DNA among male partners of Israeli women with genital premalignant and human papillomavirus lesions","volume":"31","author":"Bar-Am","year":"1995","journal-title":"Isr J Med Sci"},{"key":"10.1016\/j.vaccine.2013.05.108_bib0170","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1471-2334-8-76","article-title":"Estimation of the incidence of genital warts and the cost of illness in Germany: a cross-sectional study","volume":"8","author":"Hillemanns","year":"2008","journal-title":"BMC Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2013.05.108_bib0175","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/01.olq.0000145851.76025.ad","article-title":"Rate and predictors of new genital warts claims and genital warts-related healthcare utilization among privately insured patients in the United States","volume":"31","author":"Koshiol","year":"2004","journal-title":"Sex Transm Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13009213?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13009213?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,10]],"date-time":"2018-10-10T18:50:36Z","timestamp":1539197436000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13009213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":35,"alternative-id":["S0264410X13009213"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.05.108","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Burden of Human Papillomavirus Infection and Related Diseases in Israel","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.05.108","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}